Emerging roles of TLR7 and TLR9 in murine SLE

Journal of Autoimmunity

Volumn 33, Issue 3-4, 2009, Pages 231-238

  Santiago Raber, Marie Laure ^a   Baudino, Lucie ^a   Izui, Shozo ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Autoantibody; Endogenous retrovirus; Lupus nephritis; Systemic lupus erythematosus; Toll like receptor

Indexed keywords

AUTOANTIBODY; GLYCOPROTEIN; GLYCOPROTEIN GP70; RIBONUCLEOPROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CHROMATIN; DENDRITIC CELL; DISEASE COURSE; DNA RNA HYBRIDIZATION; GENE DUPLICATION; GENE TRANSLOCATION; GLOMERULONEPHRITIS; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN NUCLEIC ACID INTERACTION; RETROVIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS ENVELOPE;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOGENOUS RETROVIRUSES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; VIRAL PROTEINS;

EID: 71649101226     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.10.001     Document Type: Article

References (118)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
2. Clynes R., Dumitru C., and Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998) 1052-1054
3. Wang Y., Hu Q., Madri J.A., Rollins S.A., Chodera A., and Matis L.A. Amelioration of lupus-like autoimmune disease in NZB/W F1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci USA 93 (1996) 8563-8568
4. Azeredo da Silveira S., Kikuchi S., Fossati-Jimack L., Moll T., Saito T., Verbeek J.S., et al. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med 195 (2002) 665-672
5. Takahashi S., Fossati L., Iwamoto M., Merino R., Motta R., Kobayakawa T., et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97 (1996) 1597-1604
6. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N., Izui S., Wilson C.B., McConahey P.J., et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148 (1978) 1198-1215
7. Yoshiki T., Mellors R.C., Strand M., and August J.T. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 140 (1974) 1011-1027
8. Izui S., McConahey P.J., Theofilopoulos A.N., and Dixon F.J. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med 149 (1979) 1099-1116
9. Cohen P.L., and Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferation disease. Annu Rev Immunol 9 (1991) 243-269
10. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
11. Izui S., Iwamoto M., Fossati L., Merino R., Takahashi S., and Ibnou-Zekri N. The Yaa gene model of systemic lupus erythematosus. Immunol Rev 144 (1995) 137-156
12. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., and Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312 (2006) 1669-1672
13. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103 (2006) 9970-9975
14. Vyse T.J., and Kotzin B.L. Genetic susceptibility to systemic lupus erythematosus. Ann Rev Immunol 16 (1998) 261-292
15. Wakeland E.K., Liu K., Graham R.R., and Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15 (2001) 397-408
16. Jiang Y., Hirose S., Abe M., Sanokawa-Akakura R., Ohtsuji M., Mi X., et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51 (2000) 429-435
17. Pritchard N.R., Cutler A.J., Uribe S., Chadban S.J., Morley B.J., and Smith K.G. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr Biol 10 (2000) 227-230
18. Rahman Z.S., and Manser T. Failed up-regulation of the inhibitory IgG Fc receptor FcγRIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the FcγRIIB gene. J Immunol 175 (2005) 1440-1449
19. McGaha T.L., Sorrentino B., and Ravetch J.V. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307 (2005) 590-593
20. Lin Q., Xiu Y., Jiang Y., Tsurui H., Nakamura K., Kodera S., et al. Genetic dissection of the effects of stimulatory and inhibitory IgG Fc receptors on murine lupus. J Immunol 177 (2006) 1646-1654
21. Wandstrat A.E., Nguyen C., Limaye N., Chan A.Y., Subramanian S., Tian X.H., et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21 (2004) 769-780
22. Kumar K.R., Li L., Yan M., Bhaskarabhatla M., Mobley A.B., Nguyen C., et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312 (2006) 1665-1669
23. a lupus-prone mice. J Immunol 165 (2000) 2987-2996
24. a lupus-prone mice affects ligand-binding. Int Immunol 18 (2006) 59-68
25. Haraldsson M.K., Louis-Dit-Sully C.A., Lawson B.R., Sternik G., Santiago-Raber M.L., Gascoigne N.R., et al. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity 28 (2008) 40-51
26. Murphy E.D., and Roths J. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 22 (1979) 1188-1194
27. Hudgins C.C., Steinberg R.T., Klinman D.M., Reeves M.J.P., and Steinberg A.D. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol 134 (1985) 3849-3854
28. Izui S., Higaki M., Morrow D., and Merino R. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice. Eur J Immunol 18 (1988) 911-915
29. Merino R., Shibata T., de Kossodo S., and Izui S. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur J Immunol 19 (1989) 2131-2137
30. Morel L., Croker B.P., Blenman K.R., Mohan C., Huang G., Gilkeson G., et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 97 (2000) 6670-6675
31. Haywood M.E.K., Rogers N.J., Rose S.J., Boyle J., McDermott A., Rankin J.M., et al. Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J Immunol 173 (2004) 4277-4285
32. Kikuchi S., Fossati-Jimack L., Moll T., Amano H., Amano E., Ida A., et al. Differential role of three major NZB-derived loci linked with Yaa-induced murine lupus nephritis. J Immunol 174 (2005) 1111-1117
33. - bone marrow chimeric mice. J Exp Med 174 (1991) 1023-1029
34. + B cells to produce lupus autoantibodies in vivo. Eur J Immunol 25 (1995) 3412-3417
35. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., et al. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27 (2007) 801-810
36. Santiago-Raber M.L., Kikuchi S., Borel P., Uematsu S., Akira S., Kotzin B.L., et al. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 181 (2008) 1556-1562
37. Gorden K.K., Qiu X.X., Binsfeld C.C., Vasilakos J.P., and Alkan S.S. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol 177 (2006) 6584-6587
38. Wofsy D., Kerger C.E., and Seaman W.E. Monocytosis in the BXSB model for systemic lupus erythematosus. J Exp Med 159 (1984) 629-634
39. Kikuchi S., Santiago-Raber M.L., Amano H., Amano E., Fossati-Jimack L., Moll T., et al. Contribution of Nba2 to Yaa-induced monocytosis in association with murine systemic lupus. J Immunol 176 (2006) 3240-3247
40. Geissmann F., Jung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
41. Sunderkötter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., et al. Subpopulations mouse blood monocytes differ maturation stage Inflammatory Response. J Immunol 172 (2004) 4410-4417
42. Santiago-Raber M.L., Amano H., Amano E., Baudino L., Otani M., Lin Q., et al. FcγR-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum 60 (2009) 2408-2417
43. Amano H., Amano E., Santiago-Raber M.L., Moll T., Martinez-Soria E., Fossati-Jimack L., et al. Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus. Arthritis Rheum 52 (2005) 2790-2798
44. Nimmerjahn F., and Ravetch J.V. Fcγ receptors: old friends and new family members. Immunity 24 (2006) 19-28
45. Thorens B., Mermod J.J., and Vassalli P. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell 48 (1987) 671-679
46. Hora K., Satriano J.A., Santiago A., Mori T., Stanley E.R., Shan Z., et al. Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc Natl Acad Sci USA 89 (1992) 1745-1749
47. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., and Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 (2006) 417-428
48. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499-511
49. Gilliet M., Cao W., and Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8 (2008) 594-606
50. Blanco P., Palucka A.K., Gill M., Pascual V., and Banchereau J. Induction of dendritic cell differentiation by IFN-a in systemic lupus erythematosus. Science 294 (2001) 1540-1543
51. Boule M.W., Broughton C., Mackay F., Akira S., Marshak-Rothstein A., and Rifkin I.R. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199 (2004) 1631-1640
52. Lövgren T., Eloranta M.L., Båve U., Alm G.V., and Rönnblom L. Induction of interferon- α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50 (2004) 1861-1872
53. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., and Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 19 (2003) 837-847
54. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
55. Sano H., and Morimoto C. Dna isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J Immunol 128 (1982) 1341-1345
56. Barrat F.J., Meeker T., Gregorio J., Chan J.H., Uematsu S., Akira S., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202 (2005) 1131-1139
57. Savarese E., Chae O.W., Trowitzsch S., Weber G., Kastner B., Akira S., et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 107 (2006) 3229-3234
58. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19 (1998) 56-59
59. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411 (2001) 207-211
60. Cohen P.L., Caricchio R., Abraham V., Camenisch T.D., Jennette C., Roubey R.A.S., et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196 (2002) 135-140
61. Tonietti G., Oldstone M.B., and Dixon F.J. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med 132 (1970) 89-109
62. Santiago-Raber M.L., Baccala R., Haraldsson K.M., Choubey D., Stewart T.A., Kono D.H., et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 197 (2003) 777-788
63. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202 (2005) 1171-1177
64. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 202 (2005) 1575-1585
65. Berland R., Fernandez L., Kari E., Han J.H., Lomakin I., Akira S., et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25 (2006) 429-440
66. Chaturvedi A., Dorward D., and Pierce S.K. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 28 (2008) 799-809
67. Barrat F.J., Meeker T., Chan J.H., Guiducci C., and Coffman R.L. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37 (2007) 3582-3586
68. Tabeta K., Hoebe K., Janssen E.M., Du X., Georgel P., Crozat K., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7 (2006) 156-164
69. Fairhurst A.M., Hwang S.H., Wang A., Tian X.H., Boudreaux C., Zhou X.J., et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur J Immunol 38 (2008) 1971-1978
70. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., and Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202 (2005) 321-331
71. Ehlers M., Fukuyama H., McGaha T.L., Aderem A., and Ravetch J.V. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 203 (2006) 553-561
72. Wu X., and Peng S.L. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54 (2006) 336-342
73. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol 177 (2006) 1349-1354
74. Yu P., Wellmann U., Kunder S., Quintanilla-Martinez L., Jennen L., Dear N., et al. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol 18 (2006) 1211-1219
75. Wang J., Shao Y., Bennett T.A., Shankar R.A., Wightman P.D., and Reddy L.G. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem 281 (2006) 37427-37434
76. Mellors R.C., Aoki T., and Huebner R.J. Further implication of murine leukemia-like virus in the disorders of NZB mice. J Exp Med 129 (1969) 1045-1062
77. Mellors R.C., Shirai T., Aoki T., Huebner R.J., and Krawczynski K. Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med 133 (1971) 113-132
78. Izui S., McConahey P.J., Clark J.P., Hang L.M., Hara I., and Dixon F.J. Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis. J Exp Med 154 (1981) 517-528
79. Maruyama N., Furukawa F., Nakai Y., Sasaki Y., Ohta K., Ozaki S., et al. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB x NZW)F1 hybrid and the correlation to renal disease. J Immunol 130 (1983) 740-746
80. Vyse T.J., Drake C.G., Rozzo S.J., Roper E., Izui S., and Kotzin B.L. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J Clin Invest 98 (1996) 1762-1772
81. Haywood M.E.K., Vyse T.J., McDermott A., Thompson E.M., Ida A., Walport M.J., et al. Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone BXSB mice. J Immunol 167 (2001) 1728-1733
82. Lerner R.A., Wilson C.B., Villano B.C., McConahey P.J., and Dixon F.J. Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med 143 (1976) 151-166
83. Del Vellano B.C., Nave B., Croker B.P., Lerner R.A., and Dixon F.J. The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med 141 (1975) 172-187
84. Stockert E., Old L.J., and Boyse E.A. The GIX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med 133 (1971) 1334-1355
85. Tung J.S., Vitetta E.S., Fleissner E., and Boyse E.A. Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med 141 (1975) 198-205
86. Morse III H.C., Chused T.M., Boehm-Truitt M., Mathieson B.J., Sharrow S.O., and Hartley J.W. XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. J Immunol 122 (1979) 443-454
87. Obata Y., Stockert E., Yamaguchi M., and Boyse E.A. Source and hormone-dependence of G IX-gp70 in mouse serum. J Exp Med 148 (1978) 793-798
88. Hara I., Izui S., and Dixon F.J. Murine serum glycoprotein gp70 behaves as an acute phase reactant. J Exp Med 155 (1982) 345-357
89. Baudino L., Yoshinobu K., Morito N., Kikuchi S., Fossati-Jimack L., Morley B.J., et al. Dissection of genetic mechanisms governing the expression of serum retroviral gp70 implicated in murine lupus nephritis. J Immunol 181 (2008) 2846-2854
90. Santiago M.L., Mary C., Parzy D., Jacquet C., Montagutelli X., Parkhouse R.M.E., et al. Linkage of a major quantitative trait locus to Yaa gene-induced lupus-like nephritis in (NZW x C57BL/6)F1 mice. Eur J Immunol 28 (1998) 4257-4267
91. Laporte C., Ballester B., Mary C., Izui S., and Reininger L. The Sgp3 locus on mouse chromosome 13 regulates nephritogenic gp70 autoantigen and predisposes to autoimmunity. J Immunol 171 (2003) 3872-3877
92. Rankin J., Boyle J.J., Rose S.J., Gabriel L., Lewis M., Thiruudaian V., et al. The Bxs6 locus of BXSB mice is sufficient for high-level expression of gp70 and the production of gp70 immune complexes. J Immunol 178 (2007) 4395-4401
93. Obata Y., Ikeda H., Stockert E., and Boyse E.A. Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med 141 (1975) 188-197
94. Hara I., Izui S., McConahey P.J., Elder J.H., Jensen F.C., and Dixon F.J. Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. Proc Natl Acad Sci USA 78 (1981) 4397-4401
95. Oliver P.L., and Stoye J.P. Genetic analysis of Gv1, a gene controlling transcription of endogenous murine polytropic proviruses. J Virol 73 (1999) 8227-8234
96. Krebs C.J., Larkins L.K., Price R., Tullis K.M., Miller R.D., and Robins D.M. Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression. Genes Dev 17 (2003) 2664-2674
97. Bulliard Y., Wiznerowicz M., Barde I., and Trono D. KRAB can repress lentivirus proviral transcription independently of integration site. J Biol Chem 281 (2006) 35742-35746
98. Yoshinobu K., Baudino L., Morito N., Dunand-Sauthier I., Morley B.J., Evans L.H., et al. Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice. J Immunol 182 (2009) 8094-8103
99. Stoye J.P., and Coffin J.M. The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J Virol 61 (1987) 2659-2669
100. Elder J.H., Jensen F.C., Bryant M.L., and Lerner R.A. Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differential antigens encoded by a multi-gene family. Nature 267 (1977) 23-28
101. Elder J.H., Gautsch J.W., Jensen F.C., Lerner R.A., Chused T.M., Morse H.C., et al. Differential expression of two distinct xenotropic viruses in NZB mice. Clin Immunol Immunopathol 15 (1980) 493-501
102. Levy J.A. Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science 182 (1973) 1151-1153
103. Marin M., Tailor C.S., Nouri A., Kozak S.L., and Kabat D. Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses. J Virol 73 (1999) 9362-9368
104. Croker Jr. B.P., del Villano B.C., Jensen F.C., Lerner R.A., and Dixon F.J. Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB/c x NZB)F1 mice by Scripps leukemia virus. J Exp Med 140 (1974) 1028-1048
105. Krieg A.M., Khan A.S., and Steinberg A.D. Expression of an endogenous retroviral transcript is associated with murine lupus. Arthritis Rheum 32 (1989) 322-329
106. Krieg A.M., and Steinberg A.D. Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies. J Clin Invest 86 (1990) 809-816
107. Tucker R.M., Roark C.L., Santiago-Raber M.L., Izui S., and Kotzin B.L. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus. Arthritis Rheum 50 (2004) 3626-3636
108. + x 129)F1 mice: relation to naturally occurring antibodies against murine leukemia virus-related cell surface antigens. Proc Natl Acad Sci USA 76 (1979) 5289-5293
109. Mackay I.R., Leskovsek N.V., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
110. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., and Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29 (2007) 1-9
111. Shoenfeld Y., Selmi C., Zimlichman E., and Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31 (2008) 325-330
112. Witebsky E., Rose N.R., and Shulman S. Studies on organ specificity. I. The serological specificity of thyroid extracts. J Immunol 75 4 (1955) 269-281
113. Fairweather D., and Rose N.R. Inflammatory heart disease: a role for cytokines. Lupus 14 9 (2005) 646-651
114. Silverstein A.M., and Rose N.R. On the implications of polyclonal B cell activation. Nat Immunol 4 10 (2003) 931-932
115. Chen C.Y., Kimura H., Landek-Salgado M.A., Hagedorn J., Kimura M., Suzuki K., et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology 150 1 (2009) 492-499
116. Blank M., and Gershwin M.E. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
117. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 30 (2008) 105-107
118. Whittingham S., Rowley M.J., and Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 31 (2008) 197-200